The dystrobrevin binding protein 1 (DTNBP1) gene is associated with schizophrenia in the Irish Case Control Study of Schizophrenia (ICCSS) sample

Schizophrenia Research

Volumn 115, Issue 2-3, 2009, Pages 245-253

  Riley, Brien ^a,b,c   Kuo, Po Hsiu ^a,c   Maher, Brion S ^a,b,c   Fanous, Ayman H ^a,c,d,e   Sun, Jingchun ^a,c   Wormley, Brandon ^a,c   O'Neill, F Anthony ^f   Walsh, Dermot ^g   Zhao, Zhongming ^a,c   Kendler, Kenneth S ^a,b,c  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^d GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^g HEALTH RESEARCH BOARD   (Ireland)

Author keywords

Association; Case control; DTNBP1; Dysbindin; Genetic; Schizophrenia

Indexed keywords

DYSBINDIN;

ALLELE; ARTICLE; BIOINFORMATICS; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; GENE LOCATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC MARKER; HAPLOTYPE; HUMAN; HUMAN VERSUS ANIMAL COMPARISON; IRELAND; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; SCHIZOPHRENIA; SECONDARY ANALYSIS; SEQUENCE ANALYSIS; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

CARRIER PROTEINS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; COMPUTATIONAL BIOLOGY; FAMILY HEALTH; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; IRELAND; LOGISTIC MODELS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SCHIZOPHRENIA;

EID: 71649113424     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2009.09.008     Document Type: Article

References (53)

1. Andreasen N.C., Endicott J., Spitzer R.L., and Winokur G. The family history method using diagnostic criteria. Reliability and validity. Arch. Gen. Psychiatry 34 (1977) 1229-1235
2. Bakker S.C., Hoogendoorn M.L., Hendriks J., Verzijlbergen K., Caron S., Verduijn W., Selten J.P., Pearson P.L., Kahn R.S., and Sinke R.J. The PIP5K2A and RGS4 genes are differentially associated with deficit and non-deficit schizophrenia. Genes Brain Behav. 6 (2007) 113-119
3. Barrett J.C., Fry B., Maller J., and Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21 (2005) 263-265
4. Bray N.J., Preece A., Williams N.M., Moskvina V., Buckland P.R., Owen M.J., and O'Donovan M.C. Haplotypes at the dystrobrevin binding protein 1 (DTNBP1) gene locus mediate risk for schizophrenia through reduced DTNBP1 expression. Hum. Mol. Genet. 14 (2005) 1947-1954
5. Cavalli-Sforza L.L., Menozzi P., and Piazza A. The History and Geography of Human Genes (1994), Princeton University Press, Princeton, NJ
6. Chen X., Wang X., Hossain S., O'Neill F.A., Walsh D., van den O.E., Fanous A., and Kendler K.S. Interleukin 3 and schizophrenia: the impact of sex and family history. Mol. Psychiatry 12 (2007) 273-282
7. Datta S.R., McQuillin A., Puri V., Choudhury K., Thirumalai S., Lawrence J., Pimm J., Bass N., Lamb G., Moorey H., Morgan J., Punukollu B., Kandasami G., Kirwin S., Sule A., Quested D., Curtis D., and Gurling H.M. Failure to confirm allelic and haplotypic association between markers at the chromosome 6p22.3 dystrobrevin-binding protein 1 (DTNBP1) locus and schizophrenia. Behav. Brain Funct. 3 (2007) 50
8. DeLuca V., Voineskos D., Shinkai T., Wong G., and Kennedy J.L. Untranslated region haplotype in dysbindin gene: analysis in schizophrenia. J. Neural Transm. 112 (2005) 1263-1267
9. Duan J., Martinez M., Sanders A.R., Hou C., Burrell G.J., Krasner A.J., Schwartz D.B., and Gejman P.V. DTNBP1 (Dystrobrevin binding protein 1) and schizophrenia: association evidence in the 3' end of the gene. Hum. Hered. 64 (2007) 97-106
10. Endicott J., Andreasen N., and Spitzer R.L. Family History Research Diagnostic Criteria Biometrics Research Department (1978), New York State Psychiatric Institute, New York
11. Funke B., Finn C.T., Plocik A.M., Lake S., DeRosse P., Kane J.M., Kucherlapati R., and Malhotra A.K. Association of the DTNBP1 locus with schizophrenia in a U.S. population. Am. J. Hum. Genet. 75 (2004) 891-898
12. Gabriel S.B., Schaffner S.F., Nguyen H., Moore J.M., Roy J., Blumensteil B., Higgins J., DeFelice M., Lochner A., Faggart M., Rotimi C., Adeyemo A., Cooper R., Ward R., Lander E.S., Daly M.J., and Altschuler D. The structure of haplotype blocks in the human genome. Science 296 (2002) 2225-2229
13. Gruber J.D., Genissel A., Macdonald S.J., and Long A.D. How repeatable are associations between polymorphisms in achaete-scute and bristle number variation in Drosophila?. Genetics 175 (2007) 1987-1997
14. Hall D., Gogos J.A., and Karayiorgou M. The contribution of three strong candidate schizophrenia susceptibility genes in demographically distinct populations. Genes Brain Behav. 3 (2004) 240-248
15. Hill E.W., Jobling M.A., and Bradley D.G. Y-chromosome variation and Irish origins. Nature 404 (2000) 351-352
16. Holliday E.G., Handoko H.Y., James M.R., McGrath J.J., Nertney D.A., Tirupati S., Thara R., Levinson D.F., Hayward N.K., Mowry B.J., and Nyholt D.R. Association study of the dystrobrevin-binding gene with schizophrenia in Australian and Indian samples. Twin Res. Hum. Genet. 9 (2006) 531-539
17. Joo E.J., Lee K.Y., Jeong S.H., Ahn Y.M., Koo Y.J., and Kim Y.S. The dysbindin gene (DTNBP1) and schizophrenia: no support for an association in the Korean population. Neurosci. Lett. 407 (2006) 101-106
18. Kendler K.S., and Diehl S.R. The genetics of schizophrenia: a current, genetic-epidemiologic perspective. Schizophrenia Bull. 19 (1993) 261-285
19. Kendler K.S., O'Neill F.A., Burke J., Murphy B., Duke F., Straub R.E., Shinkwin R., Ni N.M., MacLean C.J., and Walsh D. Irish study on high-density schizophrenia families: field methods and power to detect linkage. Am. J. Med. Genet. 67 (1996) 179-190
20. Kirov G., Ivanov D., Williams N.M., Preece A., Nikolov I., Milev R., Koleva S., Dimitrova A., Toncheva D., O'Donovan M.C., and Owen M.J. Strong evidence for association between the dystrobrevin binding protein 1 gene (DTNBP1) and schizophrenia in 488 parent-offspring trios from Bulgaria. Biol. Psychiatry 55 (2004) 971-975
21. Li T., Zhang F., Liu X., Sun X., Sham P.C., Crombie C., Ma X., Wang Q., Meng H., Deng W., Yates P., Hu X., Walker N., Murray R.M., St Clair D., and Collier D.A. Identifying potential risk haplotypes for schizophrenia at the DTNBP1 locus in Han Chinese and Scottish populations. Mol. Psychiatry. 10 (2005) 1037-1044
22. Lin P.I., Vance J.M., Pericak-Vance M.A., and Martin E.R. No gene is an island: the flip-flop phenomenon. Am. J. Hum. Genet. 80 (2007) 531-538
23. Liu C.M., Liu Y.L., Fann C.S., Yang W.C., Wu J.Y., Hung S.I., Chen W.J., Chueh C.M., Liu W.M., Liu C.C., Hsieh M.H., Hwang T.J., Faraone S.V., Tsuang M.T., and Hwu H.G. No association evidence between schizophrenia and dystrobrevin-binding protein 1 (DTNBP1) in Taiwanese families. Schizophr. Res. 93 (2007) 391-398
24. Maher, B.S., Reimers, M.A., Riley, B.P., Kendler, K.S., submitted for publication. Allelic heterogeneity in genetic association meta-analysis: an application to DTNBP1 and schizophrenia. Human Heredity.
25. Maki P., Veijola J., Jones P.B., Murray G.K., Koponen H., Tienari P., Miettunen J., Tanskanen P., Wahlberg K.E., Koskinen J., Lauronen E., and Isohanni M. Predictors of schizophrenia-a review. Br. Med. Bull. 73-74 (2005) 1-15
26. McEvoy B., Richards M., Forster P., and Bradley D.G. The Longue Duree of genetic ancestry: multiple genetic marker systems and Celtic origins on the Atlantic facade of Europe. Am. J. Hum. Genet. 75 (2004) 693-702
27. Morris D.W., McGhee K.A., Schwaiger S., Scully P., Quinn J., Meagher D., Waddington J.L., Gill M., and Corvin A.P. No evidence for association of the dysbindin gene [DTNBP1] with schizophrenia in an Irish population-based study. Schizophr. Res. 60 (2003) 167-172
28. Numakawa T., Yagasaki Y., Ishimoto T., Okada T., Suzuki T., Iwata N., Ozaki N., Taguchi T., Tatsumi M., Kamijima K., Straub R.E., Weinberger D.R., Kunugi H., and Hashimoto R. Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia. Hum. Mol. Genet. 13 (2004) 2699-2708
29. Pedrosa E., Locker J., and Lachman H.M. Survey of schizophrenia and bipolar disorder candidate genes using chromatin immunoprecipitation and tiled microarrays (ChIP-chip). J. Neurogenet. 23 (2009) 341-352
30. Pedrosa E., Ye K., Nolan K.A., Morrell L., Okun J.M., Persky A.D., Saito T., and Lachman H.M. Positive association of schizophrenia to JARID2 gene. Am. J. Med. Genet. B Neuropsychiatr. Genet. 144B (2007) 45-51
31. Peters K., Wiltshire S., Henders A.K., Dragovic M., Badcock J.C., Chandler D., Howell S., Ellis C., Bouwer S., Montgomery G.W., Palmer L.J., Kalaydjieva L., and Jablensky A. Comprehensive analysis of tagging sequence variants in DTNBP1 shows no association with schizophrenia or with its composite neurocognitive endophenotypes. Am. J. Med. Genet. B Neuropsychiatr. Genet. (2008) 10.1002/ajmg.b.30741
32. Redon R., Ishikawa S., Fitch K.R., Feuk L., Perry G.H., Andrews T.D., Fiegler H., Shapero M.H., Carson A.R., Chen W., Cho E.K., Dallaire S., Freeman J.L., Gonzalez J.R., Gratacos M., Huang J., Kalaitzopoulos D., Komura D., MacDonald J.R., Marshall C.R., Mei R., Montgomery L., Nishimura K., Okamura K., Shen F., Somerville M.J., Tchinda J., Valsesia A., Woodwark C., Yang F., Zhang J., Zerjal T., Zhang J., Armengol L., Conrad D.F., Estivill X., Tyler-Smith C., Carter N.P., Aburatani H., Lee C., Jones K.W., Scherer S.W., and Hurles M.E. Global variation in copy number in the human genome. Nature 444 (2006) 444-454
33. Relethford J.H. Genetic structure and population history of Ireland: a comparison of blood group and anthropometric analyses. Ann. Hum. Biol. 10 (1983) 321-333
34. Roy M.A., Walsh D., and Kendler K.S. Accuracies and inaccuracies of the family history method: a multivariate approach. Acta Psychiatr. Scand. 93 (1996) 224-234
35. Sanders A.R., Duan J., Levinson D.F., Shi J., He D., Hou C., Burrell G.J., Rice J.P., Nertney D.A., Olincy A., Rozic P., Vinogradov S., Buccola N.G., Mowry B.J., Freedman R., Amin F., Black D.W., Silverman J.M., Byerley W.F., Crowe R.R., Cloninger C.R., Martinez M., and Gejman P.V. No significant association of 14 candidate genes with schizophrenia in a large European ancestry sample: implications for psychiatric genetics. Am. J. Psychiatry 165 (2008) 497-506
36. SAS Institute. SAS. [v9]. Cary, NC. Ref Type: Computer Program (2002)
37. Schwab S.G., Knapp M., Mondabon S., Hallmayer J., Borrmann-Hassenbach M., Albus M., Lerer B., Rietschel M., Trixler M., Maier W., and Wildenauer D.B. Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families. Am. J. Hum. Genet. 72 (2003) 185-190
38. Semino O., Passarino G., Oefner P.J., Lin A.A., Arbuzova S., Beckman L.E., De B.G., Francalacci P., Kouvatsi A., Limborska S., Marcikiae M., Mika A., Mika B., Primorac D., Santachiara-Benerecetti A.S., Cavalli-Sforza L.L., and Underhill P.A. The genetic legacy of Paleolithic Homo sapiens sapiens in extant Europeans: a Y chromosome perspective. Science 290 (2000) 1155-1159
39. Spitzer R.L., Williams J.B., and Gibbon J. Structured Clinical Interview for DSM-III-R-Patient Version (SCID-P, 4/1/87) (1987), New York State Psychiatric Institute, New York
40. Straub R.E., Jiang Y., MacLean C.J., Ma Y., Webb B.T., Myakishev M.V., Harris-Kerr C., Wormley B., Sadek H., Kadambi B., Cesare A.T., Gibberman A., O'Neill F.A., Walsh D., and Kendler K.S. Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of mouse dysbindin, is associated with schizophrenia. Am. J. Hum. Genet. 71 (2002) 337-348
41. Straub R.E., MacLean C.J., O'Neill F.A., Burke J., Murphy B., Duke F., Shinkwin R., Webb B.T., Zhang J., Walsh D., and Kendler K.S. A potential vulnerability locus for schizophrenia on chromosome 6p24-22: evidence for genetic heterogeneity. Nat. Gen. 11 (1995) 287-293
42. Sunderland E., Tills D., Bouloux C., and Doyl J. Genetic studies in Ireland. In: Roberts D.F., and Sunderland E. (Eds). Genetic Variation in Britain Volume XII (1973), Taylor & Francis Ltd, London 141-170
43. Tang J.X., Zhou J., Fan J.B., Li X.W., Shi Y.Y., Gu N.F., Feng G.Y., Xing Y.L., Shi J.G., and He L. Family-based association study of DTNBP1 in 6p22.3 and schizophrenia. Mol Psychiatry 8 (2003) 717-718
44. Tochigi M., Zhang X., Ohashi J., Hibino H., Otowa T., Rogers M., Kato T., Okazaki Y., Kato N., Tokunaga K., and Sasaki T. Association study of the dysbindin (DTNBP1) gene in schizophrenia from the Japanese population. Neurosci. Res. 56 (2006) 154-158
45. Tosato S., Ruggeri M., Bonetto C., Bertani M., Marrella G., Lasalvia A., Cristofalo D., Aprili G., Tansella M., Dazzan P., Diforti M., Murray R.M., and Collier D.A. Association study of dysbindin gene with clinical and outcome measures in a representative cohort of Italian schizophrenic patients. Am J Med Genet B Neuropsychiatr Genet. (2007)
46. Turunen J.A., Peltonen J.O., Pietilainen O.P., Hennah W., Loukola A., Paunio T., Silander K., Ekelund J., Varilo T., Partonen T., Lonnqvist J., and Peltonen L. The role of DTNBP1, NRG1, and AKT1 in the genetics of schizophrenia in Finland. Schizophr. Res. 91 (2007) 27-36
47. Van Den Bogaert A., Schumacher J., Schulze T.G., Otte A.C., Ohlraun S., Kovalenko S., Becker T., Freudenberg J., Jonsson E.G., Mattila-Evenden M., Sedvall G.C., Czerski P.M., Kapelski P., Hauser J., Maier W., Rietschel M., Propping P., Nothen M.M., and Cichon S. The DTNBP1 (dysbindin) gene contributes to schizophrenia, depending on family history of the disease. Am. J. Hum. Genet. 73 (2003) 1438-1443
48. van den Oord E., Sullivan P.F., Chen X., Kendler K.S., and Riley B. Identification of a high risk haplotype for the dystrobrevin binding protein 1 (DTNBP1) gene in the Irish study of high density schizophrenia families. Mol Psychiatry. 8 (2003) 499-510
49. van den Oord E.J.C.G., Jiang Y., Riley B.P., Kendler K.S., and Chen X. FP-TDI SNP genotype scoring by manual and statistical procedures: a study of error rates and types. Biotechniques 34 (2003) 610-624
50. Vilella E., Costas J., Sanjuan J., Guitart M., De D.Y., Carracedo A., Martorell L., Valero J., Labad A., De F.R., Najera C., Molto M.D., Toirac I., Guillamat R., Brunet A., Valles V., Perez L., Leon M., de Fonseca F.R., Phillips C., and Torres M. Association of schizophrenia with DTNBP1 but not with DAO, DAOA, NRG1 and RGS4 nor their genetic interaction. J Psychiatr Res. (2007) 10.1016/j.jpsychires.2007.02.005
51. Williams N.M., Preece A., Morris D.W., Spurlock G., Bray N.J., Stephens M., Norton N., Williams H., Clement M., Dwyer S., Curran C., Wilkinson J., Moskvina V., Waddington J.L., Gill M., Corvin A.P., Zammit S., Kirov G., Owen M.J., and O'Donovan M.C. Identification in 2 independent samples of a novel schizophrenia risk haplotype of the dystrobrevin binding protein gene (DTNBP1). Arch. Gen. Psychiatry 61 (2004) 336-344
52. Wood L.S., Pickering E.H., and Dechairo B.M. Significant support for DAO as a schizophrenia susceptibility locus: examination of five genes putatively associated with schizophrenia. Biol. Psychiatry 61 (2007) 1195-1199
53. Zaykin D.V., Meng Z., and Ehm M.G. Contrasting linkage-disequilibrium patterns between cases and controls as a novel association-mapping method. Am. J. Hum. Genet. 78 (2006) 737-746